Synopsis The current study demonstrated that transcatheter closure of symptomatic paravalvular leaks (PVL) is a reasonable, primarily symptomatic treatment option for patients at increased surgical risk. For reasonable efficacy rates and low complication rates interventional PVL closure has the ability to become a first line approach in the treatment of PVL in patients at increased surgical risk in the future. This week's 'MED FACT' discusses a clinical trial from Clinical Research in Cardiology, “ Interventional treatment of paravalvular regurgitation by plug implantation following prosthetic valve replacement: a single-center experience” , 2018.
Authors : Werner N, Zeymer U, Fraiture B, et.al. Key Takeaways Transcatheter closure of symptomatic PVL is a reasonable, primarily symptomatic treatment option for patients at increased surgical risk. Objective Study Type Participants To…
